Unknown NA INTERVENTIONAL 3-arm NCT02613078

Hypnotherapy vs. Probiotics in Children With IBS and Functional Abdominal Pain

Gut-Directed Hypnotherapy vs. Probiotics in Children and Adolescents With Irritable Bowel Syndrome and Functional Abdominal Pain - A Pilot Study

Sponsor: SymbioPharm GmbH

Conditions Functional Abdominal Pain Syndrome Irritable Bowel Syndrome

Interventions Gut-Directed Hypnotherapy Nutritional Supplement Self-Monitoring

Updated 6 times since 2017 Last updated: Mar 2, 2016 Started: Mar 31, 2016 Primary completion: Apr 30, 2017 Completion: Oct 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Functional Abdominal Pain Syndrome and Irritable Bowel Syndrome and is currently ongoing. SymbioPharm GmbH leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Mar 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Mar 2018 [monthly]

Recruiting NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SymbioPharm GmbH
University Hospital Tuebingen

Data source: University Hospital Tuebingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tübingen, Germany